Decorative Graphic
Important Notice
This Inari Medical website and all product offerings listed are tailored for the United States only. Please be aware that product availability and regulatory claims may vary in other regions we serve, including Europe, the Middle East, and Africa (EMEA), Asia-Pacific (APAC), and Latin America/Canada. Inari Medical is currently developing separate websites for our products tailored to these other global and regional markets.
Decorative Graphic
VTE Excellence is the multidisciplinary,
systematic approach that’s
transforming VTE care.
VTE Excellence
THE LONG-AWAITED, VITAL COMMITMENT
TO STANDARDIZING VTE PATIENT CARE.
VTE Excellence: A systematic approach to VTE patient care
VENOUS
THROMBOEMBOLISM
VTE encompasses both deep vein thrombosis (DVT), blood clots in the deep veins of the body, and pulmonary embolism (PE), which occurs when DVT travels to the lungs. VTE is a major cause of death and disability worldwide. Despite its prevalence and severity, VTE is underdiagnosed and undertreated.
Affects over
900,000 Americans
each year1
>200,000
deaths

annually1
1 in 5 patients
are readmitted
within 30 days2
Since 2013, Inari Medical has revolutionized the standard of care for venous disease with innovative, purpose-built devices. Inari’s mission to treat and transform the lives of patients suffering from venous disease extends into multiple programs specifically designed to advance awareness and treatment of VTE.
Over 100,000 patients treated
Comprehensive VTE physician education
Leading clinical data
Comprehensive VTE program development
FRAGMENTED
PATIENT PATHWAY
A non-standardized approach to VTE patient care LEADS TO a fragmented patient pathway RESULTING IN inconsistent triage, treatment and follow-up.
TRIAGE
75% of intermediate-high risk PE
patients do not receive interventional consult3
TREATMENT
90% VTE patients receive
conservative medical management4
FOLLOW-UP
38% VTE patients are lost at
follow-up within 90 days of discharge5
PULMONOLOGY
EMERGENCY
MEDICINE
HEMATOLOGY
HOSPITAL
MEDICINE
VASCULAR SURGERY
INTERVENTIONAL
CARDIOLOGY
INTERVENTIONAL
RADIOLOGY
CRITICAL CARE
MEDICINE
VTE
PATIENT
VTE EXCELLENCE
Systematic Approach to VTE Patient Care
The VTE Excellence approach to patient care was developed in partnership with venous disease experts who have successfully solved existing fragmented patient pathways and improved VTE clinical outcomes. Like pathways developed to improve patient outcomes for myocardial infarction (MI) and stroke, VTE Excellence ensures that patients who should receive interventional consultation for venous disease are not missed.
FRAGMENTED PATHWAY
VTE EXCELLENCE
Unrecognized patient identification process
IDENTIFICATION
Standardized patient identification & consultation
No defined protocols
PROTOCOL
Multidisciplinary agreed-upon algorithm for triage & treatment
Limited exposure to the latest in device technology
EXPERIENCE
Multiple operators who consult & treat with the latest options
Lack of disease awareness & treatment options
EDUCATION
Peer-to-peer collaboration & evidence-based treatment
No VTE coordinator
COORDINATOR
Dedicated VTE coordinator
Limited awareness across hospital & community
OUTREACH
Comprehensive communication across hospital & community
“The success of our VTE Excellence program has been driven by a robust, systematic process for identifying patients who can benefit from intervention.”
—Michael Knox, MD, FACR
Interventional Radiologist
Advanced Radiology Services – Grand Rapids
Spectrum Health Hospitals
STRATEGIC APPROACH TO PROGRAM
DEVELOPMENT
Inari Medical is pioneering the treatment of venous disease through long-term, strategic partnerships through the Inari Solutions Group (ISG). ISG partners with health systems and physicians to improve patient pathways, clinical outcomes, health economics and disease awareness.
Patient Pathway
Customized processes to appropriately identify and treat patients that improve:
  • Triage
  • Treatment
  • Follow-up
Clinical Outcomes
Access to purpose-built medical devices and training support designed to improve:
  • Mortality
  • Resource utilization
  • Readmission and LOS
Health Economics
Comprehensive support to provide tailored assistance with:
  • Resource efficiencies
  • Reimbursement
  • Coding and billing support
Disease Awareness
Tools to expand understanding of disease and advanced therapy options, including:
  • Media
  • Patient testimonials
  • Inreach and outreach
References:
1. Centers for Disease Control and Prevention. Venous Thromboembolism (Blood Clots). Data & Statistics.
2. Secemsky E et al. High Burden of 30-Day Readmissions After Acute Venous Thromboembolism in the United States. Journal of American Heart Association. 2018.
3. Lacey MJ et al. Prospective Experience of Pulmonary Embolism Management and Outcomes. J Invasive Cardiol. 2021.
4. Key N et al. Current Treatment of Venous Thromboembolism. Arterioscler Thromb Vasc Biol. March 2010.
5. Rokosh R et al. High Incidence of patients lost to follow-up after venous thromboembolism diagnosis— Identifying an unmet need for targeted transition of care. Vascular. 2021.